Public Readiness and Emergency Preparedness Act (PREP Act)

Public Readiness and Emergency Preparedness Act The Public Readiness and Emergency Preparedness Act (PREP Act) authorizes the Secretary of the Department of Health and Human Services (Secretary) to issue a declaration (PREP Act declaration) that provides immunity from liability (except for willful misconduct) for claims of loss caused, arising out of, relating to, or resulting from administration or use of countermeasures to diseases, threats and conditions determined by the Secretary to constitute a present, or credible risk of a future public health emergency to entities and individuals involved in the development, manufacture, testing, distribution, administration, and use of such countermeasures. A PREP Act declaration is specifically for the purpose of providing immunity from liability, and is different from, and not dependent on, other emergency declarations. Current Declarations COVID-19 - Medical Countermeasures (effective February 4, 2020) Ammended April 10, 2020 to add countermeasures pursuant to the CARES Act OGC Advisory Opinion on PREP Act Declaration Ebola Disease Vaccines - Amendment (effective December 1, 2018) Ebola Disease Therapeutics - Amendment (effective December 1, 2018) Nerve Agents and Certain Insecticides (Organophosphorus and/or Carbamate) Countermeasures (effective April 11, 2017) Zika Virus Vaccines (effective August 1, 2016) Pandemic Influenza Medical Countermeasures (amended effective January 1, 2016) Anthrax Medical Countermeasures (amended effective January 1, 2016) Acute Radiation Syndrome Medical Countermeasures (amended effective January 1, 2016) Botulinum Toxin Medical Countermeasures (amended effective January 1, 2016) Smallpox Medical Countermeasures (amended effective January 1, 2016)